Drawing for BIOGRAFT

USPTO serial 88363214

BIOGRAFT

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SEVERSON, JUSTIN
Law office
TMO LAW OFFICE 111 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with BIOGRAFT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Bone cement for medical purposes; Bone cement for surgical and orthopaedic purposes; Bone cement for surgical and orthopedic purposes; Bone fillers consisting of living materials; Bone growth media consisting of biological materials for medical purposes; Bone morphogenetic protein for use as a bone growth media; Bone paste for medical purposes; Bone repair paste for use in orthopedic surgery; Bone void fillers consisting of biological materials; Bone void fillers consisting of natural materials; Bone wax for use in surgical procedures; Arterial grafts; Biological tissue grafts; Biological bone tissue intended for subsequent implantation; Cement for bones for medical use; Culture media for use in bone grafting; Human allograft bone and tissue; Media for use in the augmentation of bone and tissue for medical purposes; Natural biomaterials for augmentation of bone and tissue for medical purposes; Pharmaceutical products for the treatment of bone diseases; Skin graftsACTIVE—
010Bone densitometer for use in the diagnosis of osteoporosis; Bone forceps; Bone implants composed of artificial materials; Bone prostheses; Bone repair compound for use in orthopedic surgery; Bone retractors; Bone scrapers; Bone screws; Bone setting machines and instruments; Bone substitutes for surgical use; Bone void filler consisting of synthetic materials; Bone void fillers consisting of artificial materials; Bone void fillers consisting primarily of synthetic materials and also incorporating biological materials; Artificial bone growth media; Artificial bone parts to be implanted in natural bones; Artificial bones for implantation; Artificial biomaterials for augmentation of bone and tissue for medical purposes; Artificial vascular grafts; Biodegradable bone fixation implants; Dental and medical drill bits for cutting teeth or bone; Electric bone operating machines; External orthopedic devices using electrical signals to stimulate bone growth; Medical apparatus and instruments for treating osteoarthritis, osteoporosis, osteotraumatic injuries, degenerative bone diseases and joint diseases; Medical apparatus and instruments for treating osteotraumatic injuries, degenerative bone diseases and joint diseases; Medical devices, namely, bone mineral densitometer (BMD) machines; Prosthetic and filling materials, namely, artificial materials for use in the replacement of bones; Prosthetic and filling materials, namely, putty for use in the replacement of bones; Substitutes for bones, cartilage, ligaments and tendons; Synthetic bone grafts; Synthetic bone substitute compound, namely, phosphocalcic granules; Synthetic filler and extender material to serve as replacement for bone; Synthetic media for use in the augmentation of bone and tissue for medical purposes; Synthetic stent grafts; Ultrasonic bone densitometer with computer, printer, and computer software for use therewith, sold as a unit, for medical diagnostic useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Dec 30, 2019MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 30, 2019ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 17, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 17, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 17, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 10, 2019DOCKASSIGNED TO EXAMINER—
Apr 17, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 2, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance